Description
Austedo XR (deutetrabenazine extended-release) is a prescription medicine designed to manage involuntary movements in patients with Huntington’s disease chorea and tardive dyskinesia. The extended-release formula allows once-daily dosing, offering convenience and steady symptom control throughout the day. Austedo XR uses include improving motor control, reducing abnormal movements, and enhancing overall quality of life for patients living with these neurological conditions. By regulating dopamine activity in the brain, Austedo XR helps restore balance and decrease the excessive movements that interfere with daily living.
|
Fact Table
|
|
Formula
|
C19H21D6NO3
|
|
License
|
US DailyMed
|
|
Bioavailability
|
less than 10%
|
|
Legal status
|
Prescription Required
|
|
Chemical Name
|
Deutetrabenazine
|
|
Elimination half-life
|
9–10 hours
|
|
Dosage (Strength)
|
6mg, 12mg, 24mg, Titration Kit (6mg, 12mg, 24mg)
|
|
Pregnancy
|
Consult a doctor - safety in human pregnancy is unknown
|
|
Brands
|
Austedo XR
|
|
Protein binding
|
60–65% bound to plasma proteins
|
|
PubChem CID
|
73437646
|
|
MedlinePlus
|
a617022
|
|
ChEBI
|
Unknown
|
|
ATC code
|
N07XX16
|
|
DrugBank
|
DB12161
|
|
KEGG
|
D10701
|
|
Routes of administration
|
Oral (by mouth)
|
Directions
Austedo XR dosing is typically started at a low level and gradually increased under medical supervision to reach an effective dose that balances benefits with tolerability. The tablets are taken once daily with food to ensure proper absorption. Patients should not split, crush, or chew the tablets. Always follow your doctor’s instructions and do not adjust your dose without consulting your healthcare provider. The specific Austedo XR dosing schedule may vary depending on whether it is prescribed for Huntington’s chorea or tardive dyskinesia.
Ingredients
The active ingredient in Austedo XR is deutetrabenazine. Each extended-release tablet also contains inactive ingredients that may include lactose monohydrate, microcrystalline cellulose, magnesium stearate, and coating agents that help with absorption and stability. These components are carefully formulated to provide consistent release of medication throughout the day.
Interactions
Austedo XR can interact with certain medicines, including monoamine oxidase inhibitors (MAOIs), reserpine, strong CYP2D6 inhibitors, and alcohol. Combining Austedo XR with other medications that affect dopamine or serotonin may increase the risk of side effects. Always provide your healthcare professional with a full list of prescriptions, supplements, and over-the-counter products before starting Austedo XR.
Cautions
Patients should inform their doctor about any history of depression, suicidal thoughts, liver disease, or irregular heart rhythms before beginning treatment. Austedo XR may cause drowsiness, so caution is advised when driving or operating machinery until you know how the medicine affects you. This medication may not be suitable for individuals with untreated depression or severe hepatic impairment. Pregnant and breastfeeding women should consult their healthcare provider before using this medication.
Side Effects
Austedo XR side effects may include sleepiness, fatigue, diarrhea, and dry mouth. Some patients may also experience restlessness, insomnia, or mood changes. Rare but serious side effects include worsening depression or suicidal thoughts, which require immediate medical attention. Most Austedo XR side effects are mild to moderate and can often be managed by adjusting the dose under medical supervision.
IMPORTANT NOTE:
The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.
Product Code : 15440